Latest Breaking News On - Point pharmaceuticals - Page 11 : comparemela.com

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Receives $33 86 Average PT from Analysts

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned an average rating of “Buy” from the seven ratings firms that are covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have covered the stock in the last […]

Darioa paggiarinoEyepoint pharmaceuticals incToth financial advisory corpJpmorgan chase coTower research capitalEyepoint pharmaceuticalsEyepoint pharmaceuticals price performanceNews ratings for eyepoint pharmaceuticals dailyUs bancorpChina universal asset management coInvestment advisersSecurities exchange commissionAnalyst recommendations for eyepoint pharmaceuticalsHedge funds weigh in on eyepoint pharmaceuticalsGet free reportMarketbeat ratings

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesMacau generalChristina tartagliastern irdirectEyepoint pharmaceuticals incBetta pharmaceuticalsEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticalsEquinox sciencesPoint pharmaceuticalsAnnual healthcareFireside chatdateAnnual healthy altitudesChristina tartagliastern

EyePoint Pharmaceuticals: Innovating Eye Treatment, Yet A Hold At This Time (EYPT)

EyePoint Pharmaceuticals: Innovating Eye Treatment, Yet A Hold At This Time (EYPT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesZorica nastasicIcon bioscience incEyepoint pharmaceuticalsEyepoint pharmaceuticals incSivida corpPoint pharmaceuticalsIcon bioscienceEyepoint investor presentation januaryAge related macular degenerationNon proliferative diabetic retinopathyDiabetic macular edemaGeographic atrophySeeking alpha

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMacau generalHong kongChristina tartagliastern irdirectEyepoint pharmaceuticalsEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticals incEquinox sciencesCompensation committeeBetta pharmaceuticalsPoint pharmaceuticalsTerm incentive planEyepoint pharmaceuticalChristina tartagliasternAmy phillipsgreen room communicationsdirect

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Macau generalUnited statesHong kongAmy phillipsStefan klotterChristina tartagliaGreen room communicationsEyepoint pharmaceuticals nasdaqBetta pharmaceuticalsEyepoint pharmaceuticalsEyepoint pharmaceuticals incCompensation committeeEquinox sciencesPoint pharmaceuticalsTerm incentive planEyepoint pharmaceutical